Clinical Trial Update: Comparison Between Rebamipide 2% Versus Autologous Serum [Phase 4]

View source ↗

Summary

Phase 4 trial comparing rebamipide 2% to autologous serum in patients with dry eye syndromes and Sjögren syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome
• Sjögren Syndrome

Drugs mentioned

• Autologous Serum
• rebamipide 2% (rebamipide)

Snippet

Sponsor: Hospital Nacional Profesor Alejandro Posadas | Conditions: Dry Eye Syndromes, Sjögren Syndrome | Phase 4 | Status: COMPLETED